Laboratorio de Biofarmacéuticos Recombinantes, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Avenida Dr. Manuel Nava 6, San Luis Potosí, 78210, México; Sección de Biotecnología, Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, Avenida Sierra Leona 550, Lomas Segunda Sección, San Luis Potosí, 78210, México.
Laboratorio de Bioseparaciones, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Avenida Dr. Manuel Nava 6, SLP, 78210, México.
Trends Biotechnol. 2017 Mar;35(3):241-256. doi: 10.1016/j.tibtech.2016.12.002. Epub 2017 Jan 30.
Immunotherapies constitute an important trend in developing new cancer treatments, and several promising candidates are under evaluation in clinical trials. Plants have entered the fight against cancer because they constitute low-cost and efficient hosts for biopharmaceutical production that can also serve as oral delivery vehicles. This review is focused on the knowledge gained through the development of anticancer plant-made vaccines reported thus far, and highlights the potential of this technology - its success being reflected in the number of candidates that are close to market. Future prospects for anticancer plant-made vaccines are also identified.
免疫疗法是开发新癌症治疗方法的一个重要趋势,有几个有前途的候选药物正在临床试验中进行评估。植物已经进入抗癌领域,因为它们是低成本、高效的生物制药生产宿主,也可以作为口服给药载体。本综述重点介绍了迄今为止开发抗癌植物制造疫苗所获得的知识,并强调了该技术的潜力——其成功反映在接近市场的候选药物数量上。还确定了抗癌植物制造疫苗的未来前景。